FIG. 1.
CatB activity is required for entry of ZEBOV GP-dependent entry, whereas CatL activity is dispensable. Vero cells were pretreated for 4 h with 1% (vol/vol) DMSO (vehicle), 0.5 μM FYdmk (CatL-selective inhibitor), 80 μM CA074 (CatB-selective inhibitor), 0.5 μM FYdmk plus 80 μM CA074, or 300 μM E64 (pan-cysteine cathepsin inhibitor). (A) The cells were then challenged with VSV-GPΔMuc, CHT-derived VSV-GP18K (CHT-GP18K), THL-derived VSV-GP17K (THL-GP17K), or VSV-G pseudotypes at a low MOI (0.02 to 0.1 eGFP-positive infectious units [iu] per cell) in the presence of drug, and viral titers (iu/ml) were determined at 18 h postinfection. CatB and CatL activities in extracts prepared from a parallel set of pretreated cells were measured by fluorogenic peptide turnover and are shown (bottom). Averages ± standard deviations (SD) for six trials from three independent experiments are shown. CatL activity below the detection threshold is indicated as zero without an accompanying SD. (B) Vero cells pretreated with protease inhibitors were challenged with VSV-GPΔMuc, cathepsin L-derived VSV-GP18K (CatL-GP18K), or cathepsin B-derived VSV-GP17K (CatB-GP17K), and viral infectivity was measured as described above. Averages ± SD for three trials from a representative experiment are shown.